Overcoming Racial Disparities in Screening Mammography

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40+
SponsorWashington University School of Medicine

About this trial

The purpose of this study is to increase screening mammography among Black women by implementing and evaluating a culturally tailored patient-centric program designed to address barriers to screening. By performing a randomized clinical trial, this study aims to develop effective strategies to improve adherence to screening mammography and contribute to reducing health disparities in breast cancer outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Woman

At least 40 years old

Self-identify as Black

English-speaking

Disqualifiers

A previous history of breast cancer

Scheduled for a diagnostic mammogram

Has a documented or uncorrectable cognitive, hearing, or visual impairment.

Too ill to participate (diagnosed with or suffering from a condition that, in the judgment of the investigator, may limit participation in the study).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Appointment mail reminder

    Other intervention

    Patient will receive an appointment reminder in the mail 7-10 days prior to the appointment.

  • Telephone counseling

    Other intervention

    The telephone counseling will include an appointment reminder within 7 days of their appointment and identify and troubleshoot barriers to patient's mammography completion.

  • Digital navigation video

    Other intervention

    The digital navigation video will explain the rationale for the mammogram and the mammography procedure. Digital navigation video will be sent by SMS text message 1-3 days prior to the appointment.

  • Automated phone call

    Other intervention

    Patient will receive an automated reminder phone call for their appointment 1-3 days prior to the appointment.

Treatment groups

176 Participants
are divided into 2 treatment groups
Group A: Arm 1: Usual CareActive comparator 1 intervention
Group B: Arm 2: Culturally Tailored Patient Centric Program MethodsExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

No-show rate

Defined as the proportion of participants who do not complete (or do not reschedule) their screening mammogram appointment within 6 months of randomization.

Time frame
6 months after randomization

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Washington University School of Medicine

Lead sponsor

National Comprehensive Cancer Network

Collaborator

Novartis

Collaborator

This trial is not recruiting at the moment. You can still explore other options: